PATHOGEN ASSOCIATED MALIGNANCIES (PAM) The overall focus of this program is to study pathogen-associated malignancies (PAM) to better prevent, diagnose, and treat these cancers. We will place an emphasis on studying host-pathogen interactions to identify novel vulnerabilities caused by the pathogens and will use this information to design prevention or treatment strategies. We will focus on anogenital and oropharyngeal cancers caused by human papillomaviruses (HPV), Merkel cell carcinoma (MCC) caused by Merkel cell polyomavirus (MCPyV), gastric cancers caused by Helicobacter pylori (H. pylori), Kaposi sarcoma and other lymphomas caused by Kaposi sarcoma herpesvirus (KSHV), liver cancers caused by hepatitis B and C viruses (HBV, HCV), and both lymphomas and epithelial cancers caused by Epstein Barr virus (EBV). Additionally, we will study the role that specific bacteria or the microbiome play in promoting cancer and in modifying response to treatment modalities.
The specific aims of the program are (1) to study host-pathogen interactions of PAMs to identify mechanisms of cancer induction and exploitable vulnerabilities, (2) to support translational studies of PAMs in preclinical and clinical settings that can inform the design of better prevention or therapeutic strategies, and (3) to implement effective public health measures to eliminate PAMs and adapt the advances in cancer research made in resource-rich countries to address the cancer burdens of low income countries. The PAM Program currently has 37 members with 14 members having primary appointments at Fred Hutch, 22 members at University of Washington, and 1 member at Seattle Children?s. The current research support of PAM members is $26.4M (direct costs), of which $7.6M is peer-reviewed funding, including $2M from the NCI. The PAM program published a total of 377 papers in the last grant period, of which 16% were intra- programmatic, 44% were inter-programmatic, 52% were inter-institutional, and 45% had external co-authors. Program members have utilized all 12 of the Consortium Shared Resources. This P30 grant also assists this program by providing administrative and logistical support for PAM meetings, pilot funding for new research projects, and recruitment resources for new faculty.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-46
Application #
10125971
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Jeong, Kyoung Sook; Zhou, Jin; Griffin, Stephanie C et al. (2018) MicroRNA Changes in Firefighters. J Occup Environ Med 60:469-474
Appelbaum, Jacob; Wells, David; Hiatt, Joseph B et al. (2018) Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report. J Immunother Cancer 6:82
Blair, Kris M; Mears, Kevin S; Taylor, Jennifer A et al. (2018) The Helicobacter pylori cell shape promoting protein Csd5 interacts with the cell wall, MurF, and the bacterial cytoskeleton. Mol Microbiol 110:114-127
Talarico, Sarah; Korson, Andrew S; Leverich, Christina K et al. (2018) High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter 23:e12472
Bhatia, Shailender; Miller, Natalie J; Lu, Hailing et al. (2018) Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma. Clin Cancer Res :
Chozinski, Tyler J; Mao, Chenyi; Halpern, Aaron R et al. (2018) Volumetric, Nanoscale Optical Imaging of Mouse and Human Kidney via Expansion Microscopy. Sci Rep 8:10396
Holly, Mayumi K; Smith, Jason G (2018) Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. J Virol :
Cheng, Heather H (2018) The resounding effect of DNA repair deficiency in prostate cancer. Urol Oncol 36:385-388
Poudel, Kumud R; Roh-Johnson, Minna; Su, Allen et al. (2018) Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis. Dev Cell 45:738-752.e6
Eaton, Keith D; Romine, Perrin E; Goodman, Gary E et al. (2018) Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility. J Thorac Oncol 13:649-659

Showing the most recent 10 out of 1267 publications